These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27653840)

  • 1. Parathyroid hormone metabolism and signaling in health and chronic kidney disease.
    Evenepoel P; Bover J; Ureña Torres P
    Kidney Int; 2016 Dec; 90(6):1184-1190. PubMed ID: 27653840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease.
    Evenepoel P; Jørgensen HS
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):383-390. PubMed ID: 38651491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease.
    Bover J; Arana C; Ureña P; Torres A; Martín-Malo A; Fayos L; Coll V; Lloret MJ; Ochoa J; Almadén Y; Guirado L; Rodríguez M
    Nefrologia (Engl Ed); 2021; 41(5):514-528. PubMed ID: 36165134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications.
    Kritmetapak K; Pongchaiyakul C
    Int J Nephrol; 2019; 2019():5496710. PubMed ID: 31637056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone measurement in CKD.
    Souberbielle JC; Roth H; Fouque DP
    Kidney Int; 2010 Jan; 77(2):93-100. PubMed ID: 19812537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic regulation of circulating PTH: significance in health and in disease.
    D'Amour P
    Clin Biochem; 2012 Aug; 45(12):964-9. PubMed ID: 22569597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New Developments in CKD-MBD. Cell Biology of parathyroid in CKD].
    Kakuta T; Sawada K
    Clin Calcium; 2014 Dec; 24(12):1801-8. PubMed ID: 25423925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Activity of Different Forms of Oxidized Parathyroid Hormone.
    Hasan AA; Hocher CF; Kleuser B; Krämer BK; Hocher B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Garrett G; Sardiwal S; Lamb EJ; Goldsmith DJ
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):299-312. PubMed ID: 22403273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?
    Evenepoel P; Rodriguez M; Ketteler M
    Semin Nephrol; 2014 Mar; 34(2):151-63. PubMed ID: 24780470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomatous Colon Polyps in Diabetes: Increased Prevalence in Patients with Chronic Kidney Disease and Its Association with Parathyroid Hormone.
    Chowdhury DN; Botros Y; DeBari VA; Baddoura W; Chandran CB
    Ann Clin Lab Sci; 2016 Dec; 46(6):608-615. PubMed ID: 27993873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity.
    Ulmer CZ; Kritmetapak K; Singh RJ; Vesper HW; Kumar R
    J Am Soc Nephrol; 2022 Aug; 33(8):1448-1458. PubMed ID: 35396262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
    Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K; Ong L; Sethi SK; Saw S
    Clin Biochem; 2013 Jun; 46(9):781-6. PubMed ID: 23384535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.